ACELYRIN investor relations material

Listen to the latest call from ACELYRIN

ACELYRIN, INC. is a Los Angeles area-based late-stage clinical biopharmaceutical company – with additional operations in the San Francisco Bay area – focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates. ACELYRIN, INC. went public in May 2023.

  • Ticker

  • Country


Dig deeper into the ACELYRIN fundamentals on Quartr.